BBMRI-ERIC

BBMRI-ERIC
Name	BBMRI-ERIC
Formation	2013
Type	Research Infrastructure
Headquarters	Vienna
Region served	Europe
Membership	Member States, Observer States

BBMRI-ERIC

BBMRI-ERIC is a European research infrastructure for biobanking and biomolecular resources that coordinates networks of biobanks, research centers, universities, hospitals, and policy bodies across Europe. It connects national facilities, regional initiatives, academic centers and international consortia to support translational research, precision medicine, pharmacogenomics and epidemiology. BBMRI-ERIC enables sample and data access, standardization and interoperability among stakeholders including ministries, regulatory agencies, funding bodies and patient organizations.

Overview

BBMRI-ERIC functions as a distributed research infrastructure linking national biobanking nodes such as the Dutch national node, the Finnish Institute for Health and Welfare, the UK Biobank, the French National Institute of Health and Medical Research, the German Biobank Alliance and other facilities in collaboration with universities like University of Oxford, Karolinska Institutet, University of Cambridge, Heidelberg University, University of Barcelona and hospitals including Charité – Universitätsmedizin Berlin, Hôpital Pitié-Salpêtrière, St Thomas' Hospital, Rigshospitalet. It interfaces with international initiatives such as Innovative Medicines Initiative, Horizon 2020, Horizon Europe, Human Cell Atlas, European Research Council, European Medicines Agency and connects to disease-focused consortia like European Cancer Organisation, European Society of Cardiology, European Respiratory Society and patient groups such as European Patients' Forum. BBMRI-ERIC supports data sharing frameworks related to projects funded by agencies like Wellcome Trust, Bill & Melinda Gates Foundation, National Institutes of Health, European Molecular Biology Laboratory, European Bioinformatics Institute and standards organizations including International Organization for Standardization, Clinical and Laboratory Standards Institute and Health Level Seven International.

History and Establishment

The establishment of BBMRI-ERIC followed preparatory phases involving research networks, member states, science ministries and funding bodies inspired by earlier initiatives like European Molecular Biology Laboratory collaborations, the European Strategy Forum on Research Infrastructures, and national biobank programs such as the Icelandic Heart Association and the Estonian Genome Project. Formal legal creation under the ERIC statute was shaped by negotiations among ministries from countries including Austria, France, Germany, Italy, Spain and Sweden, with foundational meetings involving representatives from institutions like European Commission, Council of the European Union, European Parliament committees and research councils. Early projects aligned BBMRI-ERIC with multinational studies such as EPIC (European Prospective Investigation into Cancer and Nutrition), FinnGen and the 1000 Genomes Project.

Governance and Membership

Governance of BBMRI-ERIC is built around a statutory Assembly of Members formed by national delegates from ministries, research councils and national nodes such as the Norwegian Institute of Public Health, the Swiss Biobanking Platform, the Czech National Node and the Polish National Centre for Research and Development. The governance framework engages advisory bodies, a directorate, committees and working groups involving representatives from institutions like European University Association, Organisation for Economic Co-operation and Development, World Health Organization Regional Office for Europe and professional societies such as European Society of Human Genetics. Membership includes full Member States and Observer States with participation from research organizations including Max Planck Society, Centre National de la Recherche Scientifique, Karolinska Institutet and hospitals like University Hospital Leuven.

Structure and Services

BBMRI-ERIC provides a catalogue service, negotiation support, quality management, sample access tools and IT interoperability platforms connecting local biobanks hosted by universities and hospitals such as University College London, University of Milan, Leiden University Medical Center and research centers like Francis Crick Institute. Core services integrate with data infrastructures like ELIXIR, European Genome-phenome Archive, Global Alliance for Genomics and Health and cloud platforms used by organizations such as Amazon Web Services, Google Cloud Platform and national e-infrastructures. Service provision includes legal and ethical support involving authorities like European Data Protection Board, European Court of Justice (in matters of data protection jurisprudence), and standards bodies such as Council of Europe committees on human rights and bioethics.

Biobanking Infrastructure and Standards

BBMRI-ERIC promotes harmonization of biobanking procedures across institutions like Institute of Cancer Research, National Cancer Institute, Rijksinstituut voor Volksgezondheid en Milieu and national biobank networks through adoption of standards from International Organization for Standardization (ISO 15189, ISO 20387), and best practices aligned with projects such as SPIDIA4P, B3Africa and P3G (Public Population Project in Genomics). It supports quality management systems, sample annotation standards using terminologies like SNOMED CT, LOINC, Human Phenotype Ontology and data models interoperable with OMOP Common Data Model and FHIR (Fast Healthcare Interoperability Resources). Infrastructure investments coordinate with research infrastructures like CERN (for computing models), European XFEL and national supercomputing centers.

Research Projects and Collaborations

BBMRI-ERIC participates in, coordinates or supports research projects spanning cancer, cardiovascular disease, rare diseases and infectious diseases, collaborating with consortia such as EuroBioBank, ELIXIR-CONVERGE, IMI PRECISE4Q, HARMONY Alliance, EATRIS, ISBER and academic networks including European Alliance for Personalised Medicine and European Research Area. Collaborative studies involve partnerships with pharmaceutical companies like Novartis, Roche, Sanofi, academic funders like Wellcome Sanger Institute and public health agencies including Public Health England and Robert Koch Institute.

Impact and Criticism

BBMRI-ERIC has enabled cross-border research access, contributed to large-scale genomic and epidemiological studies, and influenced policymaking in precision medicine, data protection and public health through interactions with bodies like European Commission DG Research, European Parliament committees and national parliaments. Criticism has focused on issues raised by patient advocates, ethicists and legal scholars from institutions such as University of Oxford, University of Cambridge, Helsinki University regarding consent models, data privacy under General Data Protection Regulation, governance transparency, equitable access between countries and commercialization involving industry partners like GlaxoSmithKline and Pfizer. Discussions continue among academic networks, funding agencies and civil society organizations to balance research utility with individual rights and national interests.

Category:Biobanks Category:European research infrastructures